Generic Ritalin SR
Generic Ritalin SR, which is sold under the name Methylphenidate Extended-Release tablets, is used to treat ADHD and narcolepsy. The FDA has given all generic versions of the drug an "AB" rating, meaning they should be equivalent to the brand-name version. However, it is important to keep in mind that while brand name and generic Ritalin SR are equivalent, they may have different inactive ingredients.
Ritalin SR® (methylphenidate extended-release) is a prescription medication that has been licensed to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy.
Ritalin SR was first manufactured by Novartis Pharmaceuticals Corporation. However, the patent for the drug has since expired, and generic Ritalin SR is now available.
Generic Ritalin SR is sold under the name Methylphenidate Extended-Release tablets, which come in the following strengths:
- Methylphenidate Extended-Release 10 mg tablets
- Methylphenidate Extended-Release 20 mg tablets.
Generic Ritalin SR is made by the following manufacturers:
- Mallinckrodt, Inc.
- Sandoz Pharmaceuticals
- Watson Laboratories.
All generic medications must have certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generic versions are equivalent to the brand-name medications and assigns a rating to each one. An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic Ritalin SR versions that are currently available have an "AB" rating, meaning they should be equivalent to Ritalin SR.
However, generic medications are allowed to have different inactive ingredients from the brand-name version. This includes fillers or dyes or other ingredients, which may cause problems for people with certain allergies or sensitivities.